Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02781623 · ClinicalTrials.gov registry record
Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 13
- Enrollment target
NCT02781623: Completed study, sponsored by NYU Langone Health.
NCT02781623 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02781623 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This study will quantify and examine the extent to which the quadriceps femoris muscle group atrophies following tibial plateau fractures and the length of time that atrophy affects function. The study will also look at the effects of tibial plateau fractures on the quadriceps muscle and the effect this atrophy has on functional outcome. Quadriceps atrophy will be measured both clinically and by using MRI scans taken pre-operatively, 3 months post operatively, and 1 year post-operatively. The injured leg and the non-injured leg will be scanned in order for the non-injured leg to serve as the control. In this way muscle volume can be estimated from the muscle thickness at specific locations in the thigh. The muscle strength of the quadriceps will also be assessed at the 3 month and 1 year visit by measuring isokinetic knee-extension torque, and functional assessment questionnaires will be completed at each study visit.
Primary Outcome
From the axial images obtained from the MRI for each leg, outlines of each muscle in the quadriceps femoris muscle group will be traced and used to calculate.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-10 |
| Est. Completion | 2022-01-18 |
What the finished NCT02781623 record still lists
NCT02781623 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02781623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02781623 about?
NCT02781623 is a clinical study titled "Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture". This study will quantify and examine the extent to which the quadriceps femoris muscle group atrophies following tibial plateau fractures and the length of time that atrophy affects function. The study will also look at the effects of tibial plateau fractures on the quadriceps muscle and the effect ...
What is the current status of trial NCT02781623?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-10. Estimated completion is 2022-01-18.
What interventions are being tested in trial NCT02781623?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02781623?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia